A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC)
Titel:
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC)
Auteur:
Yardley, Denise A. Young, Robyn R. Adelson, Kerin B. Silber, Andrea L. Najera, Jose E. Daniel, Davey B. Peacock, Nancy Finney, Lindsey Hoekstra, Susan J. Shastry, Mythili Hainsworth, John D. Burris, Howard A.